Does CRISABOROLE Cause Therapeutic product effect delayed? 10 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Therapeutic product effect delayed have been filed in association with CRISABOROLE (Eucrisa). This represents 0.1% of all adverse event reports for CRISABOROLE.
10
Reports of Therapeutic product effect delayed with CRISABOROLE
0.1%
of all CRISABOROLE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Therapeutic product effect delayed From CRISABOROLE?
Of the 10 reports.
Is Therapeutic product effect delayed Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CRISABOROLE. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does CRISABOROLE Cause?
Drug ineffective (1,815)
Application site pain (1,414)
Burning sensation (975)
Off label use (673)
Condition aggravated (613)
Pain (468)
Pruritus (378)
Rash (342)
Eczema (308)
Erythema (285)
What Other Drugs Cause Therapeutic product effect delayed?
ADALIMUMAB (244)
TOFACITINIB (178)
CARBIDOPA\LEVODOPA (168)
SECUKINUMAB (162)
POLYETHYLENE GLYCOL 3350 (125)
RIMEGEPANT (120)
TASIMELTEON (93)
DUPILUMAB (90)
IBUPROFEN (88)
DICLOFENAC (85)
Which CRISABOROLE Alternatives Have Lower Therapeutic product effect delayed Risk?
CRISABOROLE vs CRIZANLIZUMAB
CRISABOROLE vs CRIZANLIZUMAB-TMCA
CRISABOROLE vs CRIZOTINIB
CRISABOROLE vs CROFELEMER
CRISABOROLE vs CROMOLYN